Analysis Group Report on Biopharmaceutical Innovation Featured on PhRMA Webinar

Event:Exploring the Biopharmaceutical Pipeline
Date:January 17, 2013
Host:Pharmaceutical Research and Manufacturers of America (PhRMA)
Times:9:00–9:30 a.m. (PST) / 12:00–12:30 p.m. (EST)

Senior Advisor Genia Long participates in a PhRMA-hosted webinar to discuss a new Analysis Group report and provide insights on new treatments for U.S. patients in the biopharmaceutical pipeline. She is joined by John Lechleiter, Eli Lilly CEO and PhRMA chairman, and John Castellani, PhRMA president and CEO, to share recent findings and discuss how to ensure a favorable environment for innovation. The report, which is being covered in several media outlets, reveals that more than 5,400 potential new medicines are in the pipeline, including 1,800 for rare diseases.

Read the media coverage

Read the report

View additional information

Associated Experts & Staff